Skip to content

To use Durvadi ghrita as a wound healing agent and as an alternative to povidone iodine in wound management

A comparative study of Durvadi Ghrita and Povidone Iodine in VRANA ROPANA w.s.r to Wound Healing

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048970
Enrollment
30
Registered
2023-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L761- Accidental puncture and lacerationof skin and subcutaneous tissue during a procedure

Interventions

None listed

Sponsors

Principal R.G.G.P.G ayurvedic college and hospital Paprola
Lead Sponsor
Dr Kulwant Singh Himaliyan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for trial. Patients of age group 16-70 years. Patients with traumatic wounds and post-operative wounds.

Exclusion criteria

Exclusion criteria: Patients not willing for trial or not ready to give informed consent. Patients with ischaemic wound. Patients with Diabetes. Patients with Tubercular diseases. Patients with Fungal diseases. Patients with Chronic skin diseases. Patients with Malignancy. Patients with Coagulopathy. HIV positive patients

Design outcomes

Primary

MeasureTime frame
To assess the effect of Durvadi Ghrita on pain, exudate, surrounding skin, wound bed, itching present over the wound and to compare its effect with that of Povidone IodineTimepoint: 4 weeks

Secondary

MeasureTime frame
generate feeling of wellbeingTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Adarsh kumar

R.G.G.P.G Ayurvedic college and hospital paprola kangra

drkulwanthimaliyan@gmail.com9418251550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026